- Targeted stakeholdersRestores Medicaid reimbursement eligibility for providers that had been excluded under the repealed provision, which co…
- Targeted stakeholdersImproves continuity of care and access for Medicaid beneficiaries who received services from those entities by ensuring…
- Targeted stakeholdersReduces immediate financial strain on providers and potentially preserves health care jobs at organizations that faced…
Restoring Essential Healthcare Act
Referred to the House Committee on Energy and Commerce.
This bill, the Restoring Essential Healthcare Act, repeals Section 71113 of Public Law 119–21, which had prohibited Medicaid payments to a category of entities described in that section.
It also requires that, for items or services provided as medical assistance under a State Medicaid plan (or waiver) by any entity that would have been a “prohibited entity” under the repealed provision during the period between the enactment of Public Law 119–21 and the enactment of this repeal, payment be made as if the prohibition had never been enacted.
In short, the bill removes the statutory prohibition on Medicaid paying certain entities and makes Medicaid payments for previously excluded services payable retroactively for the specified period.
On content alone the bill is legally and administratively straightforward (which helps), but it reverses a previously enacted prohibition and orders retroactive payments. That combination tends to polarize stakeholders and raise fiscal concerns, reducing the chance of agreement in a split Congress. Absence of compromise mechanisms and unclear fiscal estimates further lower its prospects.
Relative to its intended legislative type, this bill performs a narrowly focused substantive legal change by repealing a specific statutory prohibition and imposing a retroactive payment rule, but it provides limited accompanying detail on implementation, funding, oversight, and operational mechanics.
Whether removing the statutory prohibition is primarily a pro-access, pro-provider correction (liberal) or an unacceptable rollback of a prior Congressional restriction (conservative).
Who stands to gain, and who may push back.
- Federal agenciesIncreases federal and state Medicaid outlays relative to the status quo by authorizing payment (including retroactive p…
- StatesCreates administrative burdens for state Medicaid agencies and CMS to process retroactive claims and reconcile prior de…
- Targeted stakeholdersReinstating payments to entities that had been designated as 'prohibited' could raise concerns about the original reaso…
Why the argument around this bill splits.
Whether removing the statutory prohibition is primarily a pro-access, pro-provider correction (liberal) or an unacceptable rollback of a prior Congressional restriction (conservative).
This persona would likely view the bill positively as restoring federal Medicaid funding to providers who had been excluded by Section 71113 and as preventing gaps in patient access and provider reimbursement.
They would emphasize that retroactive payment corrects an abrupt cut-off in funding and avoids leaving providers uncompensated for care already delivered.
They would also see this as aligning federal policy with broader goals of ensuring access to essential health services for low-income patients.
This persona would approach the bill with cautious pragmatism: recognizing the immediate practical benefit of restoring payments and preventing uncompensated care, while being concerned about fiscal and administrative implications.
They would weigh restoring provider payments and access against the potential costs, implementation complexity for states and the Medicaid program, and any downstream legal or policy disputes the repeal could trigger.
This persona would likely oppose the bill on the grounds that it removes a statutory prohibition on Medicaid payments to a particular category of entities and mandates retroactive federal payments.
They would express concerns about expanding or restoring federal funding to entities they consider objectionable, potential increases in Medicaid spending, federal intrusion into state program design, and erosion of policy choices made in prior legislation.
The path through Congress.
Reached or meaningfully advanced
Reached or meaningfully advanced
Still ahead
Still ahead
Still ahead
On content alone the bill is legally and administratively straightforward (which helps), but it reverses a previously enacted prohibition and orders retroactive payments. That combination tends to polarize stakeholders and raise fiscal concerns, reducing the chance of agreement in a split Congress. Absence of compromise mechanisms and unclear fiscal estimates further lower its prospects.
- The bill text references 'prohibited entity' as defined in another statute (section 71113 of Public Law 119–21). The concrete identity and activities of those entities are not specified here, and that definition materially affects political controversy and fiscal scale.
- No cost estimate or Congressional Budget Office score is included in the text; the net federal fiscal impact of retroactive payments is therefore unknown from the bill alone.
Recent votes on the bill.
No vote history yet
The bill has not accumulated any surfaced votes yet.
Go deeper than the headline read.
Whether removing the statutory prohibition is primarily a pro-access, pro-provider correction (liberal) or an unacceptable rollback of a pr…
On content alone the bill is legally and administratively straightforward (which helps), but it reverses a previously enacted prohibition a…
Relative to its intended legislative type, this bill performs a narrowly focused substantive legal change by repealing a specific statutory prohibition and imposing a retroactive payment rule, but it provides limited ac…
Go beyond the headline summary with full stakeholder mapping, legislative design analysis, passage barriers, and lens-by-lens tradeoff breakdowns.